These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29132706)

  • 21. Revising the link between proton-pump inhibitors and risk of acute myocardial infarction-a case-crossover analysis.
    Turkiewicz A; Vicente RP; Ohlsson H; Tyden P; Merlo J
    Eur J Clin Pharmacol; 2015 Jan; 71(1):125-9. PubMed ID: 25384436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncompliance with guidelines on proton pump inhibitor prescription as gastroprotection in hospitalized surgical patients who are prescribed NSAIDs.
    van den Bemt PM; Chaaouit N; van Lieshout EM; Verhofstad MH
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):857-62. PubMed ID: 27046006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proton pump inhibitors are suspected of serious adverse effects. More cautious prescribing should be considered and on correct indications].
    Backman L; Schmidt D; Vitols S
    Lakartidningen; 2013 Apr 17-23; 110(16):828-31. PubMed ID: 23717929
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clopidogrel and proton pump inhibitors--boon or bane?].
    Labenz J; Meyners W; Petersen KU
    Dtsch Med Wochenschr; 2010 Feb; 135(5):203-6. PubMed ID: 20104441
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of professional practices concerning proton pump inhibitors in general medicine].
    Rudelle K; Kazmierczak C; Grimbert D; Dumoitier N; Pfender E
    Therapie; 2023; 78(6):772-775. PubMed ID: 36841651
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?].
    Lanas A
    Gastroenterol Hepatol; 2010 Jan; 33(1):1-5. PubMed ID: 20005015
    [No Abstract]   [Full Text] [Related]  

  • 28. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence.
    Solem C; Mody R; Stephens J; Macahilig C; Gao X
    J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit].
    Dipanda M; Pioro L; Buttard M; d'Athis P; Asgassou S; Putot S; Deïdda M; Laborde C; Putot A; Manckoundia P
    Therapie; 2017 Dec; 72(6):669-675. PubMed ID: 28939010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional consequences of long-term acid suppression; are they clinically important?
    Johnson DA
    Curr Opin Gastroenterol; 2016 Mar; 32(2):136-40. PubMed ID: 26760397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review)].
    Bordin DS; Masharova AA; Lazebnik LB
    Eksp Klin Gastroenterol; 2008; (4):36-8. PubMed ID: 19145902
    [No Abstract]   [Full Text] [Related]  

  • 32. Nephrotoxic potential of proton pump inhibitors.
    Arif F
    Eur J Intern Med; 2017 Jul; 42():e16. PubMed ID: 28377063
    [No Abstract]   [Full Text] [Related]  

  • 33. [In process].
    Storr M
    Med Monatsschr Pharm; 2016 Sep; 39(9):391-5. PubMed ID: 29956514
    [No Abstract]   [Full Text] [Related]  

  • 34. General Practice Research Database for prescribing analysis.
    Frischer M; Chapman S; Bashford J; Norwood J; Heatlie H
    Lancet; 1998 Feb; 351(9100):453-4. PubMed ID: 9482346
    [No Abstract]   [Full Text] [Related]  

  • 35. The potential drug-drug interaction between proton pump inhibitors and warfarin.
    Henriksen DP; Stage TB; Hansen MR; Rasmussen L; Damkier P; Pottegård A
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1337-40. PubMed ID: 26395871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence.
    Johnson DA; Oldfield EC
    Clin Gastroenterol Hepatol; 2013 May; 11(5):458-64; quiz e37-8. PubMed ID: 23247326
    [No Abstract]   [Full Text] [Related]  

  • 37. [Does long-term use of proton pump inhibitors promote premalignant lesions of the gastric mucosa?].
    Ruetsch R; Juillerat P; Flatz A; von Elm E
    Praxis (Bern 1994); 2016 Feb; 105(4):221-2. PubMed ID: 26886699
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US.
    Rane PP; Guha S; Chatterjee S; Aparasu RR
    Res Social Adm Pharm; 2017; 13(2):358-363. PubMed ID: 27033427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National Practice Patterns of Antireflux Medication for Chronic Rhinosinusitis.
    Gilani S; Pynnonen MA; Shin JJ
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):627-33. PubMed ID: 27281111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors: a better prescription is needed.
    Khara HS; Pitchumoni CS
    J Clin Gastroenterol; 2009 Jul; 43(6):597-8. PubMed ID: 19384247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.